Blood Spot Task Group
Updated 14 January 2026
This register lists declarations made by members in respect of interests they have that are relevant to the remit of the UK National Screening Committee’s (UK NSC’s) blood spot task group (BSTG).
Dr David Elliman (chair)
- none
Dr Felicity Boardman
- interests listed on FMCH register
Dr Jim Bonham
- interests listed on FMCH register
Gina Brondel
- none
Christine Cavanagh
- works for Genomics England on the Generation Study
Dr Anupam Chakrapani
- none
Dr Llion Davies
-
Grant funding – 4 Nations research LifeArc bid in relation to rare diseases data
-
British Medical Association representative committee roles
-
Faculty of Public Health committee role and deputy faculty advisor since September 2022
Jane Fisher
- interests listed on FMCH register
Dr Sharon Hillier
- interests listed on UK NSC register
Catherine Joynson
-
member of Royal College of Physicians Committee on Ethical Issues in Medicine 2023 to 2027 (unpaid)
-
Cardiff University MSc Genetic and Genomic Counselling 2023-2026, self-funded research on Fatherhood and Cystic Fibrosis
Rachel Knowles
-
part-time employee and Clinical Principal Research Fellow at University College London (UCL)
-
part-time employee of the Medical Research Council (MRC)
-
MRC / UK Research and Innovation (UKRI) – Associate Director for Clinical Research Policy, Ethics and Governance
-
NHS England Specialist Professional and Clinical Advisor – Clinical Advisor to the Newborn Blood Spot Screening Programme
-
unpaid member of the Confidentiality Advisory Group of the Health Research Authority
Dr Robin Lachmann
- interests listed on FMCH register
Prof Mariska Leeflang
- none
Dr Helen Lewis-Parmar
- none
Prof Anneke Lucassen
- interests listed on UK NSC register
Amy Jayne McKnight
- none
Nick Meade
- CEO of Genetic Alliance UK, which received funding in 2024-25 from: Alexion, Amicus Therapeutics, BioCryst Pharmaceuticals, Biogen, Chiesi, Ipsen, Janssen, Jazz Pharmaceuticals, Johnson & Johnson, Kyowa Kirin, Novartis, Orchard Therapeutics, Pfizer, PTC Therapeutics, Roche, Sanofi, Takeda, UCB, Vertex, Genomics England, Robert Luff Foundation Trust, LifeArc, Inthallo, D’Oyly Carte Foundation, Department of Health and Social Care, Scottish Government
Prof Stuart Moat
-
Cardiff University honorary chair since 2018
-
UK MRC Grant (MR/Y008057/1): Co PI Lipidomic and Metabolomics for rare disease diagnosis
-
Waters: newborn blood spot (NBS) second tier test and diagnostic assay development, kits/reagents supplied free of charge to undertake work, publishes data
-
Revvity: NBS assay development, kits/reagents supplied free of charge to undertake work, publishes data
-
Illumina: advising on proteomic Diagnostic assay development – potential applications for newborn blood spot screening, publishes data
Dr Heather Payne
- Trustee of Representative Body of the Church in Wales (since January 2025). Elected lay member, unpaid
Liz Robinson
- none
Dr Graham Shortland
- interests listed on UK NSC register
Susan Spillane
- none
Sarah Stevens
- none
Sian Taylor-Phillips
- interests listed on UK NSC register
Dr Ellen Thomas
- works for Genomics England and is the Chief Investigator of the Generation Study
Prof Rachael Wood
- interests listed on FMCH register